2m 2m 2m 2m 2m 2m 2m
IMMUNITYBIO (IBRX)
NASDAQ
$7.20+$0.03 (+0.42%)
Price as of Jul 31, 2026 7:59 PM EDT- $7.5BMarket Cap
- 202.53%1-Year Change
- BiotechnologyIndustry
IMMUNITYBIO (IBRX)
$7.20+$0.03 (+0.42%)
IBRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.17 | ||
Change | -$0.28 (-3.76%) | ||
Open | $7.45 | ||
High | $7.62 | ||
Low | $7.10 | ||
Previous Close | $7.45 | ||
Volume | 9,319,004 | ||
30-Day Average Volume | 10,068,962 | ||
1-Week Change | 0.99% | ||
1-Month Change | -18.10% | ||
1-Year Change | 202.53% | ||
3-Year Change | 225.91% | ||
5-Year Change | -34.58% | ||
Fundamentals | |||
Shares Outstanding | 1.0B | ||
Total Assets | $646.6M | ||
Market Cap | $7.5B | ||
Enterprise Value | $8.4B | ||
Period: QTR TTM FY | |||
Revenue | $44.2M | ||
Net Income | -$632.8M | ||
Free Cash Flow | -$77.1M | ||
EBIT | -$618.9M | ||
EBITDA | -$614.5M | ||
Net Working Capital | $385.0M | ||
EPS | -$0.62 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 190 | ||
P/B | -9 | ||
P/E | -12 | ||
PEG | 0 | ||
Price/Free Cash Flow | -97 | ||
Price/Operating Cash Flow | -100 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue